The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Optimal two-stage designs for phase II clinical trials.
Simon, R. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90015-9 · Cited by 3,636
Cited by
CNS Metastases in Breast Cancer
Lin, N. U., Bellon, J. R., & Winer, E. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.175 · Cited by 715
Whole-Brain Radiotherapy in the Management of Brain Metastasis
Khuntia, D., Brown, P., Li, J., & Mehta, M. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6185 · Cited by 466
Brain Metastases: The HER2 Paradigm
Lin, N. U., & Winer, E. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2478 · Cited by 417
Management of brain metastases
Soffietti, R., Rudā, R., & Mutani, R. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0870-6 · Cited by 404
Current Management of Brain Metastases, With a Focus on Systemic Options
Langer, C. J., & Mehta, M. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.145 · Cited by 368
Metadata
- Authors
- Christodoulou, C., Bafaloukos, D., Kosmidis, P., Samantas, E., Bamias, A., Papakostas, P., Karabelis, A., Bacoyiannis, C., & Skarlos, D. V.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 12
- Issue
- 2
- Pages
- 249-254
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2162934203
- Cited by
- 174
- References
- 1
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. https://app.cochat.ai/papers/10.1023/a:1008354323167
- The paper
- Christodoulou, C., Bafaloukos, D., Kosmidis, P., Samantas, E., Bamias, A., Papakostas, P., Karabelis, A., Bacoyiannis, C., & Skarlos, D. V. (2001). Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Annals of Oncology. https://doi.org/10.1023/a%3A1008354323167
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.